Keyphrases
Postmenopausal Breast Cancer
70%
Breast Cancer Patients
65%
Tamoxifen Therapy
49%
Endometrial Pathology
37%
Endometrial Thickness
20%
Endometrium
18%
Endometrial Polyp
14%
Postmenopausal Women
12%
Postmenopausal Patients
11%
Endometrial Cancer
11%
Estrogen Receptor
10%
Doppler Flow
10%
Pregnant Women
9%
Transvaginal Ultrasonography
9%
Pathological Findings
9%
Progesterone Receptor
8%
Breast Cancer
8%
Endometrial Sampling
8%
Ovarian Tumor
8%
Colour Doppler Flow
8%
Tumor
7%
Sonographic
7%
Gonadotropin-releasing Hormone
7%
Specific Antibodies
7%
Aromatase Inhibitors
6%
Endometrial Changes
6%
Ovarian Volume
6%
Adenomyosis
6%
Ultrasonographic Examination
6%
C.trachomatis
6%
Immobilization
6%
Cyst Formation
6%
Healthy Postmenopausal Women
6%
Hysteroscopy
6%
Chlamydial Infection
6%
Hindlimb
6%
Risk Factors
6%
No Significant Difference
5%
Chlamydia Trachomatis
5%
Chemotherapy
5%
During Pregnancy
5%
Biochemical Studies
5%
Ovarian Cyst
5%
Treatment Group
5%
Malignancy
5%
Pathologic
5%
Sonohysterography
5%
Gestational Age
5%
Etiology
5%
Breast Carcinoma
5%
Medicine and Dentistry
Tamoxifen
100%
Breast Cancer
75%
Endometrium
23%
Endometrial Polyp
14%
Postmenopause
14%
Vaginal Ultrasonography
12%
Endometrial Cancer
12%
Ovarian Tumor
12%
Color Doppler Flowmetry
10%
Estrogen Receptor
10%
Progesterone Receptor
9%
Echography
9%
Diagnosis
9%
Diethylstilbestrol
9%
Neoplasm
8%
Cancer
8%
Malignant Neoplasm
7%
Hysteroscopy
7%
Ovarian Cyst
7%
Aromatase Inhibitor
6%
Blood Flow
6%
Disease
6%
Menopause
6%
Gestational Age
5%
Sonohysterography
5%
Androgen
5%
Krukenberg Tumor
5%
Breast Carcinoma
5%
Laparotomy
5%